Takeda Pharmaceutical shares are trading higher after the company announced a $600 million AI drug discovery partnership with Insilico Medic
Takeda Pharmaceutical shares are trading higher after the company announced a $600 million AI drug discovery partnership with Insilico Medicine.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.